Your browser doesn't support javascript.
loading
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?
Möller, Axel; Schwamborn, Klaus; Spillmann, Adrian; Hoogstraate, Janet; Szulkin, Robert; Akre, Olof; Egevad, Lars; Clements, Mark; Aly, Markus.
Affiliation
  • Möller A; Department of Urology, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Electronic address: axel.moller.1@ki.se.
  • Schwamborn K; VALNEVA SE, 6, rue Alain Bombard, 44800 Saint-Herblain, Nantes, France. Electronic address: klaus.schwamborn@valneva.com.
  • Spillmann A; VALNEVA AUSTRIA GMBH, Campus Vienna Biocenter 3, 1030 Vienna, Austria. Electronic address: adrian.spillmann@valneva.com.
  • Hoogstraate J; VALNEVA SWEDEN AB, SE-105 21 Stockholm, Sweden. Electronic address: janet.hoogstraate@valneva.com.
  • Szulkin R; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden; SDS Life Science, Danderyd, Sweden. Electronic address: robert.szulkin@sdslifescience.com.
  • Akre O; Department of Urology, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Electronic address: olof.akre@ki.se.
  • Egevad L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: lars.egevad@ki.se.
  • Clements M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden. Electronic address: mark.clements@ki.se.
  • Aly M; Department of Urology, Karolinska University Hospital Solna, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Electronic address: markus.aly@ki.se.
Vaccine ; 40(27): 3797-3801, 2022 06 15.
Article in En | MEDLINE | ID: mdl-35610103
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Cholera Vaccines / Cholera Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: Europa Language: En Journal: Vaccine Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Cholera Vaccines / Cholera Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: Europa Language: En Journal: Vaccine Year: 2022 Document type: Article